IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2017

Long Non-coding RNAs and their Role in Metastasis. U.H. WEIDLE, F. BIRZELE, G. KOLLMORGEN, R. RÜGER (Penzberg, Germany; Basel, Switzerland). Cancer Genomics Proteomics 14: 143-160, 2017.
Monochromosomal Hybrids and Chromosome Transfer: A Functional Approach for Gene Identification. R.P. KANDPAL, A.K. SANDHU, G. KAUR, G.P. KAUR, R.S. ATHWAL (Pomona, CA; Philadelphia, PA, USA). Cancer Genomics Proteomics 14: 93-101, 2017.
The Multiple Roles of Exosomes in Metastasis. U.H. WEIDLE, F. BIRZELE, G. KOLLMORGEN, R. RÜGER (Penzberg, Germany; Basel, Switzerland). Cancer Genomics Proteomics 14: 1-15, 2017.
Clinical and Therapeutic Implications of Follistatin in Solid Tumours. L. SHI, J. RESAUL, S. OWEN, L. YE, W.G. JIANG (Yantai, Shandong, PR China; Cardiff, UK). Cancer Genomics Proteomics 13: 425-435, 2016.
Mechanisms and Targets Involved in Dissemination of Ovarian Cancer. U.H. WEIDLE, F. BIRZELE, G. KOLLMORGEN, R. RUEGER (Penzberg, Germany; Basel, Switzerland). Cancer Genomics Proteomics 13: 407-423, 2016.
Human Uterine Cervical Stromal Stem Cells (hUCESCs): Why and How they Exert their Antitumor Activity. J. SCHNEIDER, N. EIRÓ, R. PÉREZ-FERNÁNDEZ, A. MARTÍNEZ-ORDÓÑEZ, F. VIZOSO (Valladolid; Gijón; Santiago de Compostela, Spain). Cancer Genomics Proteomics 13: 331-337, 2016.
Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia. M. MEDINGER, C. LENGERKE, J. PASSWEG (Basel, Switzerland). Cancer Genomics Proteomics 13: 317-329, 2016.
Dissection of the Process of Brain Metastasis Reveals Targets and Mechanisms for Molecular-based Intervention. U.H. WEIDLE, F. BIRZELE, G. KOLLMORGEN, R. RÜGER (Penzberg, Germany; Basel, Switzerland). Cancer Genomics Proteomics 13: 245-258, 2016.
The Significance of Proteomic Biomarkers in Male Breast Cancer. E. ZOGRAFOS, M. GAZOULI, G. TSANGARIS, E. MARINOS (Athens, Greece). Cancer Genomics Proteomics 13: 183-190, 2016.
Molecular Basis of Lung Tropism of Metastasis. U.H. WEIDLE, F. BIRZELE, G. KOLLMORGEN, R. RÜGER (Penzberg, Germany). Cancer Genomics Proteomics 13: 129-139, 2016.
Molecular Mechanisms of Bone Metastasis. U.H. WEIDLE, F. BIRZELE, G. KOLLMORGEN, R. RÜGER (Penzberg, Germany). Cancer Genomics Proteomics 13: 1-12, 2016.
Proteomics as a Guide for Personalized Adjuvant Chemotherapy in Patients with Early Breast Cancer. F. LUMACHI, G.B. CHIARA, L. FOLTRAN, S.M.M. BASSO (Padova; Pordenone, Italy). Cancer Genomics & Proteomics 12: 385-390, 2015.
Ensuring Sample Quality for Biomarker Discovery Studies – Use of ICT Tools to Trace Biosample Lifecycle. S. RIONDINO, P. FERRONI, A. SPILA, J. ALESSANDRONI, R. D’ALESSANDRO, V. FORMICA, D. DELLA-MORTE, R. PALMIROTTA, U. NANNI, M. ROSELLI, F. GUADAGNI (Rome, Italy). Cancer Genomics & Proteomics 12: 291-299, 2015.
The Blood–Brain Barrier Challenge for the Treatment of Brain Cancer, Secondary Brain Metastases, and Neurological Diseases. U.H. WEIDLE, J. NIEWÖHNER, G. TIEFENTHALER (Penzberg, Germany). Cancer Genomics & Proteomics 12: 167-177, 2015.
Caveolin-1, Breast Cancer and Ionizing Radiation. M. PUCCI, V. BRAVATÀ, G.I. FORTE, F.P. CAMMARATA, C. MESSA, M.C. GILARDI, L. MINAFRA (Cefalù; Milan; Monza, Italy). Cancer Genomics & Proteomics 12: 143-152, 2015.
TCR-MHC/Peptide Interaction: Prospects for new Anti-tumoral Agents. U.H. WEIDLE, G. GEORGES, G. TIEFENTHALER (Penzberg, Germany). Cancer Genomics & Proteomics 11: 267-277, 2014.
Tumor Interstitial Fluid: Proteomic determination as a Possible Source of Biomarkers. G. BARONZIO, G. PARMAR, M. BARONZIO, M. KISELEVSKY (Milan, Terni, Italy; Fort Langley, BC, Canada; Moscow, Russia). Cancer Genomics & Proteomics 11: 225-237, 2014.
Current State of mTOR Targeting in Human Breast Cancer. U. WAZIR, A. WAZIR, Z.S. KHANZADA, W.G. JIANG, A.K. SHARMA, K. MOKBEL (London; Cardiff, Wales, UK; Karachi, Pakistan). Cancer Genomics & Proteomics 11: 167-174, 2014.
Structure and Role of WASP and WAVe in Rho GTPase Signalling in Cancer. J. LANE, T. MARTIN, H.P. WEEKS, W.G. JIANG (Cardiff, UK). Cancer Genomics & Proteomics 11: 155-165, 2014.
Proteases as Activators for Cytotoxic Prodrugs in Antitumor Therapy. U.H. WEIDLE, G. TIEFENTHALER, G. GEORGES (Penzberg, Germany). Cancer Genomics & Proteomics 11: 267-79, 2014.
Isolation of Stem Cells Using Spheroids from Fresh Surgical Specimen: An Analytic Mini-Review. I. AVITAL, A. STOJADINOVIC, H. WANG, C. MANNION, W.-C. CHO, J. WANG, Y.-G MAN (Richmond, VA; Hackensack, NJ; Washington, DC, USA; Hangzhou; Hong Kong, P.R. China). Cancer Genomics & Proteomics 11: 57-65, 2014.
Prospects of Bacterial and Plant Protein-based Immunotoxins for Treatment of Cancer. U.H. WEIDLE, G. TIEFENTHALER, C. SCHILLER, E.H. WEISS, G. GEORGES, U. BRINKMANN (Penzberg; Munich, Germany). Cancer Genomics & Proteomics 11: 25-38, 2014.
The Translational Potential for Target Validation and Therapy Using Intracellular Antibodies in Oncology.
U.H. WEIDLE, D. MAISEL, U. BRINKMANN, G. TIEFENTHALER (Penzberg, Germany). Cancer Genomics & Proteomics 10: 239-250, 2013.
Genomics and Proteomics Approaches for Biomarker Discovery in Sporadic Colorectal Cancer with Metastasis.
M. GONZÁLEZ-GONZÁLEZ, J. GARCIA GARCIA, J.A. ALCAZAR MONTERO, L.M. GONZÁLEZ FERNANDEZ, O. BENGOECHEA, O. BLANCO MUÑEZ, A. ORFAO, J.M. SAYAGUES, M. FUENTES (Salamanca, Spain). Cancer Genomics & Proteomics 10: 19-26, 2013.
The Intriguing Options of Multispecific Antibody Formats for Treatment of Cancer.
U.H. WEIDLE, G. TIEFENTHALER, E.H. WEISS, G. GEORGES, U. BRINKMANN (Penzberg; Munich, Germany). Cancer Genomics & Proteomics 10: 1-18, 2013.
Cancer Metabolism: What we Can Learn from Proteomic Analysis by Mass Spectrometry.
W. ZHOU, L.A. LIOTTA, E.F. PETRICOIN (Manassas, VA, USA). Cancer Genomics & Proteomics 9: 373-382, 2012.
Genetically Engineered Fusion Proteins for Treatment of Cancer.
U.H. WEIDLE, B. SCHNEIDER, G. GEORGES, U. BRINKMANN (Penzberg, Germany). Cancer Genomics & Proteomics 9: 357-372, 2012.
Metastatic Biomarker Discovery Through Proteomics.
L.T. BRINTON, T.A. BRENTNALL, J.A. SMITH, K.A. KELLY (Charlottesville, VA; Seattle, WA, USA). Cancer Genomics & Proteomics 9: 345-356, 2012.
Metastasis from Oral Cancer: An Overview.
J. NOGUTI, C.F. DE MOURA, G.P. DE JESUS, V.H. DA SILVA, T.A. HOSSAKA, C.T. OSHIMA, D.A. RIBEIRO (Sao Paulo, Brazil). Cancer Genomics & Proteomics 9: 329-336, 2012.
Breast Cancer Metastasis.
O.J. SCULLY, B.-H. BAY, G. YIP, Y. YU (Singapore, Singapore). Cancer Genomics & Proteomics 9: 311-320, 2012.
Breast Cancer and Metastasis: On the Way Toward Individualized Therapy.
A.P. TRAPÉ, A.M. GONZALEZ-ANGULO (Houston, TX, USA). Cancer Genomics & Proteomics 9: 297-310, 2012.
Are we Missing the Target? – Cancer Stem Cells and Drug Resistance in Non-small Cell Lung Cancer.
S. GOTTSCHLING, P.A. SCHNABEL, F.J.F. HERTH, E. HERPEL (Heidelberg, Germany). Cancer Genomics & Proteomics 9: 275-286, 2012.
The Spectra Count Label-free Quantitation in Cancer Proteomics.
W. ZHOU, L.A. LIOTTA, E.F. PETRICOIN (Manassas, VA, USA). Cancer Genomics & Proteomics 9: 135-, 2012.
Fully Human Targeted Cytotoxic Fusion Proteins: New Anticancer Agents on the Horizon.
U.H. WEIDLE, G. GEORGES, U. BRINKMANN (Penzberg, Germany). Cancer Genomics & Proteomics 9: 119-134, 2012.
Dissection of Aberrant GPCR Signaling in Tumorigenesis – A Systems Biology Approach.
J. WU, N. XIE, X. ZHAO, E.C. NICE, C. HUANG (Chengdu, PR China; Clayton, VIC, Australia). Cancer Genomics & Proteomics 9: 37-50, 2012.
The Cancer Biomarker Osteopontin: Combination with Other Markers.
G.F. WEBER (Cincinnati, OH, USA). Cancer Genomics & Proteomics 8: 263-288, 2011.
Differential Splicing Generates New Transmembrane Receptor and Extracellular Matrix-related Targets for Antibody-based Therapyof Cancer.
U.H. WEIDLE, D. MAISEL, S. KLOSTERMANN, E.H. WEISS, M. SCHMITT (Penzberg; Planegg-Martinsried;Munich, Germany). Cancer Genomics & Proteomics 8: 211-226, 2011.
Synthetic Lethality-based Targets for Discovery of New Cancer Therapeutics.
U.H. WEIDLE, D. MAISEL, D. EICK (Penzberg; Munich, Germany). Cancer Genomics & Proteomics 8: 159-172, 2011.
Intracellular Proteins Displayed on the Surface of Tumor Cells as Targets for Therapeutic Intervention with Antibody-related Agents.
U.H. WEIDLE, D. MAISEL, S. KLOSTERMANN, C. SCHILLER, E.H. WEISS (Penzberg; Munich, Germany). Cancer Genomics & Proteomics 8: 49-64, 2011.
Interleukin 6/Interleukin 6 Receptor Interaction and its Role as a Therapeutic Target for Treatment of Cachexia and Cancer.
U.H. WEIDLE, S. KLOSTERMANN, D. EGGLE, A. KRÜGER (Penzberg; Munich, Germany). Cancer Genomics & Proteomics 7: 287-302, 2010.
ALCAM/CD166: Cancer-related Issues.
U.H. WEIDLE, D. EGGLE, S. KLOSTERMANN, G.W.M. SWART (Penzberg, Germany; Nijmegen, Netherlands). Cancer Genomics & Proteomics 7: 231-244, 2010.
TGF-β1 Interactome: Metastasis and Beyond.
M. PERERA, C.S. TSANG, R.J. DISTEL, J.N. LACY, L. OHNO-MACHADO, V. RICCHIUTI, L.P. SAMARANAYAKE, G.B. SMEJKAL, M.G. SMITH, A.J. TRACHTENBERG, W.P. KUO (Hong Kong, Hong Kong; Boston, MA; Ormond Beach, FL; La Jolla, CA, USA). Cancer Genomics & Proteomics 7: 217-230, 2010.
Cancer-related Issues of CD147.
U.H. WEIDLE, W. SCHEUER, D. EGGLE, S. KLOSTERMANN,H. STOCKINGER (Penzberg, Germany; Vienna, Austria). Cancer Genomics & Proteomics 7: 157-170, 2010.
The Role of Folate Metabolism-related Gene Polymorphisms in the Development of Meningiomas.
S.S. DRAKOS, F. ANIFANTAKI, A. ZARROS, C. LIAPI (Athens, Greece). Cancer Genomics & Proteomics 7: 105-109, 2010.
Genetic Basis and Gene Therapy Trials for Thyroid Cancer.
H. AL-HUMADI, A. ZARROS, R. ALSAIGH, C. LIAPI (Athens, Greece). Cancer Genomics & Proteomics 7: 31-50, 2010.
The Continuing Search For Predisposing Colorectal Cancer Variants.
S. PICELLI, S. VON HOLST, P. WESSENDORF (Stockholm, Sweden). Cancer Genomics & Proteomics 6: 305-316, 2009.
Pathogenetic and Clinical Relevance of MicroRNAs in Colorectal Cancer.
N. VALERI, C.M. CROCE, M. FABBRI (Columbus, OH, USA; Ferrara, Meldola, Italy). Cancer Genomics & Proteomics 6: 195-204, 2009.
Molecular Profiling for the Identification of New Biomarkers in Smokers and Cancer Patients.
K. ALBERMANN, S. LANG, R. ZEIDLER (Essen; Munich, Germany). Cancer Genomics & Proteomics 4: 349-358, 2007.
Collagen – A Necessary Accomplice in the Metastatic Process.
P.S. NERENBERG, R. SALSAS-ESCAT, C.M. STULTZ (Cambridge, MA, USA). Cancer Genomics & Proteomics 4: 319-328, 2007.
Interpreting Microarray Data: Towards the Complete Bioinformatics Toolkit for Cancer.
M.L. ROBERTS, S.D. KOTTARIDIS (Athens, Greece). Cancer Genomics & Proteomics 4: 301-308, 2007.
Page: 1 2 
Custom Tables Plugin 05a1a29bdcae7b12229e651a9fd48b11

IMPORTANT NOTE: You may submit your article only through our online submission system